Mary Puncochar - Biote Corp Chief Officer
| BTMD Stock | USD 6.10 0.10 1.61% |
Executive
Mary Puncochar is Chief Officer of biote Corp
| Phone | 844 604 1246 |
| Web | https://biote.com |
Biote Corp Management Efficiency
The company has return on total asset (ROA) of 0.1816 % which means that it generated a profit of $0.1816 on every $100 spent on assets. This is way below average. Biote Corp's management efficiency ratios could be used to measure how well Biote Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jennifer Griffin | Amedisys | N/A | |
| Keith Blanchard | Amedisys | N/A | |
| Heather CPA | Acadia Healthcare | 53 | |
| Benson Yang | Option Care Health | N/A | |
| Mia Haney | ModivCare | N/A | |
| Rebecca Orcutt | ModivCare | 39 | |
| Isa Diaz | Acadia Healthcare | N/A | |
| Nasser MD | Acadia Healthcare | 46 | |
| Brett Bearfield | Acadia Healthcare | N/A | |
| Cari Reed | Option Care Health | N/A | |
| Jessica Kral | ModivCare | N/A | |
| Chad JD | The Ensign Group | 47 | |
| Barbara CPA | ModivCare | 62 | |
| Mark Palmenter | Acadia Healthcare | N/A | |
| Scott Ginn | Amedisys | 55 | |
| Luke Whitworth | Option Care Health | 44 | |
| Femi MD | Option Care Health | N/A | |
| Dustin Lee | InnovAge Holding Corp | N/A | |
| Christine Bent | InnovAge Holding Corp | 54 | |
| Kim Harvey | Option Care Health | N/A | |
| Henry Toledo | ModivCare | N/A | |
Management Performance
| Return On Asset | 0.18 |
biote Corp Leadership Team
Elected by the shareholders, the Biote Corp's board of directors comprises two types of representatives: Biote Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biote. The board's role is to monitor Biote Corp's management team and ensure that shareholders' interests are well served. Biote Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biote Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Teresa Weber, CEO Director | ||
| Samar Kamdar, Principal CFO | ||
| Ross MD, Chief Officer | ||
| Jennifer Schimmel, Director Talent | ||
| Marc Beer, Executive Chairman | ||
| James II, Chief Officer | ||
| Robert Peterson, Chief Officer | ||
| Richard Key, Chief Marketing | ||
| Cory DO, Chief Board | ||
| Joe Butler, Chief Officer | ||
| Mary Puncochar, Chief Officer | ||
| Cary Paulette, Chief Officer | ||
| Jade Beutler, Head Nutraceuticals | ||
| Mary Conlon, General Development | ||
| John Olsen, Chief Officer |
Biote Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biote Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.18 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 276.98 M | ||||
| Shares Outstanding | 31.11 M | ||||
| Shares Owned By Insiders | 27.00 % | ||||
| Shares Owned By Institutions | 64.62 % | ||||
| Number Of Shares Shorted | 748.23 K | ||||
| Price To Earning | 0.26 X | ||||
| Price To Book | 2.96 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in biote Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.